Tailored preoperative treatment of locally advanced triple negative (hormone receptor negative and HER2 negative) breast cancer with epirubicin, cisplatin, and infusional fluorouracil followed by weekly paclitaxel. (Q46862276)
Jump to navigation
Jump to search
scientific article published on 7 December 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Tailored preoperative treatment of locally advanced triple negative (hormone receptor negative and HER2 negative) breast cancer with epirubicin, cisplatin, and infusional fluorouracil followed by weekly paclitaxel. |
scientific article published on 7 December 2007 |
Statements
Tailored preoperative treatment of locally advanced triple negative (hormone receptor negative and HER2 negative) breast cancer with epirubicin, cisplatin, and infusional fluorouracil followed by weekly paclitaxel (English)
Giuseppe Viale
Aron Goldhirsch
Alberto Luini
Luca Bottiglieri
Alessandra Balduzzi
Raffaella Ghisini
Andrea Rocca
7 December 2007